Product Program year 2024 Source: CMS Open Payments

ENROUTE Transcarotid Stent

Device Cardiology/Vascular Diseases

PDI 00811311020508

Open in the dashboard

General payments

$10,000,756

35,612 payments

Research payments

$2,850,801

671 payments

Through program year 2024, $10,000,756 in general payments and $2,850,801 in research payments were reported against ENROUTE Transcarotid Stent (Cardiology/Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2024 General $2,794,532 10,431
2024 Research $982,143 311
2023 General $2,528,159 9,411
2023 Research $1,319,829 276
2022 General $2,588,978 9,349
2022 Research $485,516 69
2021 General $2,089,088 6,421
2021 Research $63,312 15

Breakdown

Who paid General payments · program years 2021–2024
  1. Silk Road Medical, Inc. $10,000,756 35,612 payments
Top recipients General payments · program year 2024
  1. Peter Schneider Vascular Surgery · Honolulu, HI $362,289 13% · 106 payments
  2. Douglas Massop Vascular Surgery · West Des Moines, IA $172,070 6% · 112 payments
  3. Mariano Arosemena Vascular Surgery · Bradenton, FL $126,693 5% · 132 payments
  4. Enrique Criado Pallares Vascular Surgery · Midland, MI $120,000 4% · 13 payments
  5. Jeffrey Jim Vascular Surgery · Saint Louis, MO $92,433 3% · 42 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Vascular Surgery Surgery $2,005,339 74% · 1,457 practitioners
  2. Surgery $152,008 6% · 249 practitioners
  3. Physician Assistant $77,337 3% · 337 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $72,839 3% · 368 practitioners
  5. Interventional Cardiology Internal Medicine $64,187 2% · 79 practitioners

The top 5 of 85 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $599,066 21% · 310 recipients
  2. Texas $195,574 7% · 387 recipients
  3. Missouri $175,090 6% · 80 recipients
  4. Iowa $174,131 6% · 7 recipients
  5. Michigan $149,637 5% · 100 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

35,612 general · 671 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record